Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Bipolar II Disorder
NCT00156325Phase 2Completed
- Sponsor
- University of New South Wales
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of escitalopram in Bipolar II disorder (BP-II), sponsored by University of New South Wales. Started Feb 2004; status: completed.
02
Drugs
escitalopram
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT00156325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156325.